Showing results (3681-3690 of 10,080) with videos related to

Sort By:
Pageof 1,008
Current Pharmaceutical Design|February 12, 2010
Development of radiotracers for the determination of the beta-cell mass in vivoMaarten Brom, Karolina Andrałojć, Wim J G Oyen, et al.
Current Pharmaceutical Design|June 20, 2017
Protein Tyrosine Signaling and its Potential Therapeutic Implications in CarcinogenesisMihwa Kim, Minwoo Baek, Dae Joon Kim
Current Pharmaceutical Design|June 20, 2017
Recent Advances in Targeting the HIV-1 Tat/TAR ComplexFardokht A Abulwerdi, Stuart F J Le Grice
Current Pharmaceutical Design|June 20, 2017
Using β-Amino Acids and β-Peptide Templates to Create Bioactive Ligands and BiomaterialsMark P Del Borgo, Ketav Kulkarni, Marie-Isabel Aguilar
Current Pharmaceutical Design|June 20, 2017
Chemokine Like Receptor-1 (CMKLR-1) Receptor: A Potential Therapeutic Target in Management of Chemerin Induced Type 2 Diabetes Mellitus and CancerSangeetha Perumalsamy, Nurul Ain Aqilah Mohd Zin, Riyanto Teguh Widodo, et al.
Current Pharmaceutical Design|February 20, 2010
Nutlins and ionizing radiation in cancer therapyGianna Impicciatore, Silvia Sancilio, Sebastiano Miscia, et al.
Current Pharmaceutical Design|February 20, 2010
Tyrosine kinases as molecular targets to inhibit cancer progression and metastasisV Cepero, J R Sierra, S Giordano
Current Pharmaceutical Design|February 20, 2010
Development of peptides as potential drugs for cancer therapyZhi Jie Li, Chi Hin Cho
Current Pharmaceutical Design|February 20, 2010
Prostaglandin EP receptor subtypes involved in regulating HCO(3)(-) secretion from gastroduodenal mucosaKoji Takeuchi, Masafumi Koyama, Shusaku Hayashi, et al.
Current Pharmaceutical Design|July 28, 2018
Heme Oxygenase-1 and Autophagy Linked for CytoprotectionL R Vasconcellos, M S Siqueira, R Moraes, et al.
Pageof 1,008